Search

The problem of counterfeiting of drugs presents an enormous public health challenge. No area of the world is unaffected, but mounting evidence shows that the problem is disproportionately severe in developing and emerging market countries, which also have a high burden of infectious diseases such...

The production of substandard and counterfeit drugs as a result of non-adherence to good manufacturing practices by pharmaceutical companies is a vast and underreported worldwide problem particularly affecting developing countries. Developing countries are not only markets for substandard and...